New perspectives at the bench
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
PhD student Richard Fineman is using wearable sensors to understand coordination and walking — and next-generation spacesuit design.
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Base Operations, MDaaS Global, and Graviky Labs will head to Texas to be part of the first class at the new elite accelerator.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
Study debunks notion that large chunks of Medicare go to futile end-of-life care.
Mechanism-based cancer prevention is poised to further decrease the numbers of U.S. cancer deaths, says MIT professor emerita.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Algorithm makes the process of comparing 3-D scans up to 1,000 times faster.
Probiotic bacteria can diagnose, prevent, and treat infections.
“Therepi” device attaches directly to damaged heart, enabling delivery of medicine from a port under a patient’s skin to augment cardiac function.
Annamarie Bair, a premed student turned computer science major, is drawn to the promise of artificial intelligence and health care.